Home/Filings/4/0001613103-25-000115
4//SEC Filing

Quinn Michelle 4

Accession 0001613103-25-000115

CIK 0001613103other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 4:27 PM ET

Size

11.6 KB

Accession

0001613103-25-000115

Insider Transaction Report

Form 4
Period: 2025-07-28
Quinn Michelle
EVP, GC and Secretary
Transactions
  • Award

    Performance Share Units

    2025-07-28+13,59213,592 total
    Performance Share Unit (13,592 underlying)
  • Award

    Ordinary Shares

    2025-07-28+5,4375,437 total
  • Award

    Ordinary Shares

    2025-07-28+16,31021,747 total
  • Award

    Stock Option (Right to Buy)

    2025-07-28+38,33638,336 total
    Exercise: $91.97Exp: 2035-07-28Ordinary Shares (38,336 underlying)
Footnotes (6)
  • [F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
  • [F2]Represents restricted stock units that vest in three annual installments beginning one year from the date of grant.
  • [F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  • [F4]Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
  • [F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,592 shares will be issued. If maximum performance metrics are achieved, 27,184 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  • [F6]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0001964281

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:27 PM ET
Size
11.6 KB